3.0.0 2600 2019-11-15T21:18:32Z 2019-11-15T21:18:32Z House H HR 2005-05-24 109 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-06-17T15:37:42Z Referred to 2005-05-24T13:03:40Z 2005-06-17 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-05-24 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-05-24 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-05-24 Introduced in House IntroReferral 1000 9 Library of Congress S000303 Rep. Shaw, E. Clay, Jr. [R-FL-22] E. SHAW R FL CLAY 22 N O000159 Rep. Owens, Major R. [D-NY-11] MAJOR OWENS D NY R. 11 2005-05-26 False K000364 Rep. Kuhl, John R. "Randy", Jr. [R-NY-29] John Kuhl R NY R. "Randy" 29 2005-05-26 False B001247 Rep. Brown-Waite, Ginny [R-FL-5] Ginny Brown-Waite R FL 5 2005-06-08 False P000586 Rep. Putnam, Adam H. [R-FL-12] ADAM PUTNAM R FL H. 12 2005-06-17 False L000517 Rep. Lungren, Daniel E. [R-CA-3] DANIEL LUNGREN R CA EDWARD 3 2005-07-14 False Health Commerce Crime and Law Enforcement Drug adulteration Drugs Fines (Penalties) Fraud Labeling Sentences (Criminal procedure) Health 00 2005-05-24 Introduced in House 2005-08-09T15:45:05Z Prescription Drug Tampering Prevention Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to establish criminal penalties of a fine or imprisonment for any term of years or for life, or both, for: (1) knowingly causing a prescription drug to be adulterated or misbranded and selling or trading the drug; or (2) purchasing or trading for a prescription drug knowing or having reason to know that the drug was knowingly caused to be adulterated or misbranded.

Modifies provisions pertaining to criminal fines for committing certain prohibited acts involving food, drugs, devices, or cosmetics.

]]> Prescription Drug Tampering Prevention Act of 2005 Short Titles as Introduced Prescription Drug Tampering Prevention Act of 2005 Display Title Prescription Drug Tampering Prevention Act of 2005 Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act with respect to the sale or trade of prescription drugs that were knowingly caused to be adulterated or misbranded, and for other purposes. Introduced in House 2005-05-24T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr2600ih/xml/BILLS-109hr2600ih.xml 2005-06-17 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.